Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Arcutis Biotherapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 283
- +49 vs. Q3 2025
- Shares held
- 129.3M
- +3.57M (+2.8%) vs. Q3 2025
- Total value
- $3.75B
- +$1.38B (+58.4%) vs. Q3 2025
- New holders
- 74
- 103 more added
- Sold out
- 25
- 77 more reduced
5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Raymond James Financial Inc | 144,949 | $4.21M | 0.00% | +84,875+141.3% | Added |
| PDT Partners, LLC | 155,075 | $4.50M | 0.29% | +967+0.6% | Added |
| Citadel Advisors LLC | 155,158 | $4.51M | 0.00% | −22,110−12.5% | Reduced |
| Two Sigma Advisers, LP | 156,100 | $4.53M | 0.01% | +141,000+933.8% | Added |
| Rhumbline Advisers | 161,402 | $4.69M | 0.00% | −21,727−11.9% | Reduced |
| Walleye Capital LLC | 168,604 | $4.90M | 0.03% | +147,902+714.4% | Added |
| Rafferty Asset Management, LLC | 172,066 | $5.00M | 0.02% | +23,771+16.0% | Added |
| Norges Bank | 174,820 | $5.08M | 0.00% | +174,820 | New |
| Voleon Capital Management LP | 176,600 | $5.13M | 0.11% | +151,765+611.1% | Added |
| Hillsdale Investment Management Inc. | 179,420 | $5.21M | 0.14% | +179,420 | New |
| Woodline Partners LP | 195,033 | $5.66M | 0.02% | −119,586−38.0% | Reduced |
| Nordea Investment Management AB | 201,638 | $5.85M | 0.01% | +201,638 | New |
| Pavaki Capital Management LLC | 202,000 | $5.87M | 4.10% | +202,000 | New |
| FMR LLC | 205,424 | $5.97M | 0.00% | +37,450+22.3% | Added |
| Patient Square Capital LP | 210,000 | $6.10M | 1.31% | +210,000 | New |
| Swiss National Bank | 212,800 | $6.18M | 0.00% | +4,900+2.4% | Added |
| EAM Investors, LLC | 213,863 | $6.21M | 0.69% | +213,863 | New |
| Jane Street Group, LLC | 221,426 | $6.43M | 0.01% | −139,344−38.6% | Reduced |
| StemPoint Capital LP | 224,740 | $6.53M | 1.12% | −187,153−45.4% | Reduced |
| UBS Asset Management Americas Inc | 231,734 | $6.73M | 0.00% | −12,281−5.0% | Reduced |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 234,071 | $6.80M | 0.01% | +147,586+170.6% | Added |
| Prudential Financial Inc | 234,915 | $6.82M | 0.01% | +220,980+1,585.8% | Added |
| Millennium Management LLC | 236,770 | $6.88M | 0.00% | +86,671+57.7% | Added |
| MYDA Advisors LLC | 265,000 | $7.70M | 2.17% | −205,000−43.6% | Reduced |
| Renaissance Technologies LLC | 273,999 | $7.96M | 0.01% | +273,999 | New |
| Wells Fargo & Company | 284,243 | $8.25M | 0.00% | +178,986+170.0% | Added |
| Bank of New York Mellon Corp | 304,428 | $8.84M | 0.00% | −6,192−2.0% | Reduced |
| Privium Fund Management B.V. | 305,972 | $8.89M | 1.64% | 00.0% | Unchanged |
| Invesco Ltd. | 307,382 | $8.93M | 0.00% | +114,430+59.3% | Added |
| Castleark Management LLC | 309,430 | $8.99M | 0.26% | +309,430 | New |
| Jupiter Asset Management Ltd | 326,538 | $9.48M | 0.08% | −332,793−50.5% | Reduced |
| Barclays PLC | 331,578 | $9.63M | 0.00% | +5,610+1.7% | Added |
| Two Sigma Investments, LP | 400,862 | $11.6M | 0.02% | +305,433+320.1% | Added |
| First Trust Advisors LP | 404,654 | $11.8M | 0.01% | +179,689+79.9% | Added |
| Zevenbergen Capital Investments LLC | 418,035 | $12.1M | 0.27% | +418,035 | New |
| Point72 Asset Management, L.P. | 425,152 | $12.3M | 0.02% | +425,152 | New |
| Jump Financial, LLC | 430,902 | $12.5M | 0.16% | +80,417+22.9% | Added |
| Eversept Partners, LP | 434,634 | $12.6M | 0.71% | +323,168+289.9% | Added |
| Marshall Wace, LLP | 454,233 | $13.2M | 0.01% | +435,933+2,382.1% | Added |
| Squarepoint Ops LLC | 455,876 | $13.2M | 0.03% | +296,029+185.2% | Added |
| AQR Capital Management LLC | 499,418 | $14.5M | 0.01% | +58,103+13.2% | Added |
| Cormorant Asset Management, LP | 500,000 | $14.5M | 0.82% | −275,000−35.5% | Reduced |
| Capitolis Liquid Global Markets LLC | 500,000 | $14.5M | 0.09% | +500,000 | New |
| Bamco Inc | 504,700 | $14.7M | 0.04% | +504,700 | New |
| MPM Oncology Impact Management LP | 531,200 | $15.4M | 1.77% | +531,200 | New |
| Fishman Jay A Ltd | 564,650 | $16.4M | 1.35% | −1,000−0.2% | Reduced |
| Standard Life Aberdeen plc | 586,397 | $17.0M | 0.03% | −88,637−13.1% | Reduced |
| Nearwater Capital Markets, Ltd | 615,000 | $17.9M | 0.31% | +615,000 | New |
| Qube Research & Technologies Ltd | 661,415 | $19.2M | 0.03% | −153,152−18.8% | Reduced |
| BNP Paribas Arbitrage, SA | 699,803 | $20.3M | 0.01% | +653,657+1,416.5% | Added |
| Candriam Luxembourg S.C.A. | 803,138 | $23.3M | 0.12% | +25,094+3.2% | Added |
| Oberweis Asset Management Inc | 808,400 | $23.5M | 0.86% | +808,400 | New |
| Federated Hermes, Inc. | 891,767 | $25.9M | 0.04% | +132,194+17.4% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 900,000 | $26.1M | 0.04% | +900,000 | New |
| Perpetual Ltd | 910,630 | $26.4M | 0.38% | −1,113,976−55.0% | Reduced |
| Voloridge Investment Management, LLC | 914,020 | $26.5M | 0.09% | +80,530+9.7% | Added |
| Deutsche Bank AG | 930,202 | $27.0M | 0.01% | +552,674+146.4% | Added |
| Northern Trust Corp | 955,235 | $27.7M | 0.00% | +15,033+1.6% | Added |
| GW&K Investment Management, LLC | 1,008,580 | $29.3M | 0.25% | −163,461−13.9% | Reduced |
| Charles Schwab Investment Management Inc | 1,014,826 | $29.5M | 0.00% | +15,392+1.5% | Added |
| Price T Rowe Associates Inc | 1,166,348 | $33.9M | 0.00% | +1,078,546+1,228.4% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,366,624 | $39.7M | 15.34% | −753,884−35.6% | Reduced |
| Nuveen, LLC | 1,382,160 | $40.1M | 0.01% | +11,804+0.9% | Added |
| American Century Companies Inc | 1,467,176 | $42.6M | 0.02% | −195,294−11.7% | Reduced |
| Goldman Sachs Group Inc | 1,576,413 | $45.8M | 0.01% | −228,575−12.7% | Reduced |
| Bank of America Corp | 1,673,454 | $48.6M | 0.00% | +784,169+88.2% | Added |
| Janus Henderson Group PLC | 1,830,061 | $53.2M | 0.02% | −567,970−23.7% | Reduced |
| Franklin Resources Inc | 1,900,084 | $55.2M | 0.01% | −410,935−17.8% | Reduced |
| Ensign Peak Advisors, Inc | 1,902,390 | $55.2M | 0.10% | −90,665−4.5% | Reduced |
| Driehaus Capital Management LLC | 2,562,445 | $74.4M | 0.51% | +1,465,441+133.6% | Added |
| D. E. Shaw & Co., Inc. | 2,683,087 | $77.9M | 0.06% | +564,374+26.6% | Added |
| Geode Capital Management, LLC | 2,753,307 | $80.0M | 0.00% | +146,842+5.6% | Added |
| UBS Group AG | 3,243,432 | $94.2M | 0.02% | +294,994+10.0% | Added |
| Morgan Stanley | 4,340,239 | $126.0M | 0.01% | +63,845+1.5% | Added |
| Gilder Gagnon Howe & Co LLC | 4,453,856 | $129.3M | 1.37% | +24,748+0.6% | Added |
| State Street Corp | 5,488,301 | $159.4M | 0.01% | +846,986+18.2% | Added |
| Polar Capital Holdings Plc | 5,556,169 | $161.4M | 0.74% | +257,415+4.9% | Added |
| Jennison Associates LLC | 6,758,006 | $196.3M | 0.12% | −5,496,113−44.9% | Reduced |
| Vanguard Group Inc | 7,253,936 | $210.7M | 0.00% | +107,846+1.5% | Added |
| Rubric Capital Management LP | 8,271,577 | $240.2M | 2.87% | −2,477,880−23.1% | Reduced |
| BlackRock, Inc. | 9,099,579 | $264.3M | 0.00% | +525,584+6.1% | Added |
| Frazier Life Sciences Management, L.P. | 9,874,511 | $286.8M | 7.70% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 11,964,000 | $347.4M | 8.66% | +1,486,000+14.2% | Added |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −520,503−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −360,460−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −353,644−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −317,997−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −233,220−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −214,400−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −189,555−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −79,805−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −39,879−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −37,869−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −35,278−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −31,477−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −25,201−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −21,590−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −21,200−100.0% | Sold out |